Jane Street Group, LLC Oramed Pharmaceuticals Inc. Call Options Transaction History

Jane Street Group, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$8.19 - $13.89 $432,432 - $733,392	-52,800 Reduced 55.99%	41,500 $359,000
Q4 2021 Feb 15, 2022	SELL	$12.98 - $29.75 $233,640 - $535,500	-18,000 Reduced 16.03%	94,300 $1.35 Million
Q3 2021 Nov 16, 2021	BUY	$12.13 - $23.82 $1.36 Million - $2.67 Million	112,300 New	112,300 $2.47 Million

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $90.9M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.